IP Library Granted Patent US 11,937,893
Granted Patent B2
US 11,937,893 · App. 17/259,496 · Granted Mar 26, 2024

Systems and methods for light deactivation and removal of light deactivated adhesive drapes

Inventors: Timothy Mark Robinson (Wimborne, GB); Christopher Brian Locke (Bournemouth, GB); Justin Alexander Long (Lago Vista, TX); Ashwatha Price (Wimborne, GB)
Assignee: 3M Innovative Properties Company
A61B46/20A61B46/40C09J7/30C09J7/403A61B2046/205C09J2301/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,937,893
App. No.
17/259,496
Granted
Mar 26, 2024
Kind
B2
Abstract

Provided herein is a system and method for mitigating premature light deactivation of light deactivated adhesive drapes. One aspect provides a system comprising a drape, a photosensitive adhesive layer, a release agent, and an optical fiber mesh layer configured as a light pipe, where the system is adapted to be coupled to a tissue site and released therefrom upon or after exposure to an external stimulus such as certain wavelengths of light. Another aspect includes a pipe light pipe, as an alternative to the optical fiber mesh layer. The systems may have a removable blocking layer to prevent the photosensitive adhesive from being exposed to deactivation wavelengths prematurely. Another aspect provides a method for application and removal of a drape using the light pipe to transport or route light to the drape to deactivate the photosensitive adhesive layer and promote easy, clean, and less painful removal of the drape.

Claims (40)

1. A light deactivated adhesive drape system configured to be coupled to tissue, the system comprising:

a drape comprising:

a photosensitive adhesive layer having at least one release agent, wherein the at least one release agent is configured to weaken a bond of the adhesive layer to the tissue upon exposure to at least one of a plurality of light wavelengths, and

an optical fiber mesh layer configured as a light pipe; and

a blocking layer configured to block the plurality of light wavelengths that activate the at least one release agent.

2. The system of claim 1 , wherein the optical fiber mesh layer is disposed over the photosensitive adhesive layer and configured to apply the plurality of light wavelengths to a surface of the photosensitive adhesive layer.

3. The system of claim 2 , wherein the optical fiber mesh layer is configured to function as a light pipe to transport the plurality of light wavelengths to the photosensitive adhesive layer upon exposure of at least a portion of the optical fiber mesh layer to the plurality of light wavelengths.

4. The system of claim 3 , wherein the plurality of light wavelengths includes wavelengths comprising blue through violet portions of the visible light spectrum.

5. The system of claim 1 , wherein the plurality of light wavelengths includes wavelengths comprising ultraviolet light.

6. The system of claim 5 , wherein the optical fiber mesh layer is positioned between the blocking layer and the photosensitive adhesive layer.

7. The system of claim 1 , wherein the blocking layer includes one or more perforations defining an area of a removable patch.

8. The system of claim 7 , wherein a portion of the optical fiber mesh layer is configured to be exposed to the plurality of light wavelengths upon removal of the removable patch.

9. The system of claim 8 , wherein the removable patch is a peelable patch configured to be separated from the blocking layer at the one or more perforations and peeled off a surface of the optical fiber mesh layer.

10. The system of claim 1 , wherein the at least one release agent includes a plurality of photo initiators.

11. The system of claim 10 , wherein the at least one release agent includes a plurality of free radicals.

12. The system of claim 1 , further including at least one reflective material embedded into the blocking layer, the reflective material configured to reflect the light.

13. The system of claim 12 , wherein the at least one reflective material includes one or more of silver, titanium dioxide, and zinc oxide.

14. The system of claim 13 , wherein the at least one reflective material is embedded into an inner surface of the blocking layer facing the optical fiber mesh layer.

15. The system of claim 1 , further comprising: a control system coupled to the drape, the control system including:

a memory configured to store executable instructions that operate the control system;

at least one processor configured to execute the executable instructions to operate the control system; and

at least one sensor configured to sense a saturation level of the drape.

16. The system of claim 15 , wherein the at least one processor is configured to compare the sensed saturation level of the drape to a threshold saturation level to determine if the drape has reached a removal state.

17. The system of claim 16 , wherein the control system is further configured to automatically actuate a light source configured to expose the optical fiber mesh layer to the plurality of light wavelengths upon sensing the removal state of the drape.

18. A light deactivated adhesive drape system configured to be coupled to tissue, the system comprising:

a drape comprising:

a photosensitive adhesive layer having at least one release agent disposed within the adhesive layer, wherein the at least one release agent is configured to weaken a bond of the adhesive layer to the tissue upon exposure to at least one of a plurality of light wavelengths, and

a polymer light pipe; and

a blocking layer configured to block the plurality of light wavelengths that activate the at least one release agent.

19. The system of claim 18 , wherein the light pipe is one of a pneumatic or fluidic connection tube coupled to a remote therapy device.

20. The system of claim 19 , wherein the light pipe is silicone, and wherein the light pipe is flexible.

21. A method comprising:

coupling the light deactivated adhesive drape system of claim 18 to a patient's tissue;

exposing the photosensitive adhesive layer to the at least one of the plurality of light wavelengths configured to weaken the bond of the adhesive layer; and

removing the drape from the tissue.

22. The method of claim 21 , further comprising:

sensing a drape state of the drape;

comparing the drape state to a threshold corresponding to a removal state; and

determining that the drape state has reached the removal state responsive to a value of the drape state exceeding a value of the threshold.

23. The method of claim 22 , further comprising automatically actuating a light source configured to expose the light pipe to the plurality of light wavelengths upon sensing the removal state of the drape.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2024
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 066064/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2023
From: ROBINSON, TIMOTHY MARK; LOCKE, CHRISTOPHER BRIAN; LONG, JUSTIN ALEXANDER; PRICE, ASHWATHA
To: KCI LICENSING, INC.
Reel/Frame 065496/0872 →